Abbott's Compounding Pharmacy Recalls Sterile Compounded Products for Sterility Concerns
Abbott's Compounding Pharmacy is recalling all unexpired lots of sterile compounded products due to FDA inspection findings regarding lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating (Score 4) under the rubric, particularly given the risk of infection associated with lack of sterility assurance in sterile compounded products.
Plain-English summary
Abbott's Compounding Pharmacy, Inc. is recalling all unexpired lots of sterile compounded products. The recall is being conducted after an FDA inspection identified concerns regarding the lack of sterility assurance for these products.
The affected products include papaverine phentolamine prostaglandin (30/2 mg/20 mcg/mL) in 5 mL and 10 mL unit sizes. These products are compounded prescriptions that must be refrigerated. The recall covers all lots of these sterile compounded products.
Consumers who have these products should stop using them and contact their healthcare provider or the pharmacy for further instructions. The recall is limited to California (CA) based on the distribution pattern provided.
The recalled product
- Product
- papaverine phentolamine prostaglandin; 30/2 mg/20 mcg/mL; 5 mL and 10 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705
- Manufacturer
- Abbott's Compounding Pharmacy, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 43 recalled by Abbott's Compounding Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 43 products in this recall →Related recalls
Same manufacturer · Abbott's Compounding Pharmacy, Inc.
See all →- HighAbbott's Compounding Pharmacy Recalls Methylcobalamine Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Compounded Papaverine Phentolamine Products
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Compounded Products Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Compounded Products for Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Hydroxyprogesterone Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
Same hazard · sterility concern
See all →- HighSegmental Stem Components for ELEOS Limb Salvage System Recalled
FDA (Devices) · 2025-06-04
- HighMEDIHONEY Dressing Applicator Pouch Recalled for Sterility Concerns
FDA (Devices) · 2024-10-16
- HighProparacaine Hydrochloride Eye Drops Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-10-02
- HighExactech OPTETRAK Knee Implants Recalled for Out-of-Specification Vacuum Bag Packaging
FDA (Devices) · 2024-06-26
- HighPantoprazole Sodium for Injection Recalled Due to Sterility Concern
FDA (Drugs) · 2023-09-20
Similar recalls
- SevereThe Apothecary Recalls Sterile Medications Due to Sterility Assurance Issues
FDA (Drugs) · 2016-09-28
- HighCompounded Injectable Drug Recalled Due to Sterility Assurance Defect
FDA (Drugs) · 2022-11-09
- HighPharmacy Compounded Injection Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-11-09
- SevereUS Compounding Recalls Bi-Mix Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereThe Apothecary Recalls Sterile Injection Medications Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-09-28
- SevereProstaglandin Compounded Sterile Products Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12